Neuroprotective Gene Therapy for Parkinson’s Disease
Journal:
Current Gene Therapy
Volume:
2
Page:
451-483
Author(s):
L. Tenenbaum, A. Chtarto, E. Lehtonen, D. Blum, V. Baekelandt, T. Velu, J. Brotchi and M. Levivier
Cytosolic Phospholipase A2 Inhibitors as Therapeutic Agents for Neural Cell Injury
Journal:
Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents
Volume:
1
Page:
193-204
Author(s):
A. A. Farooqui, Wei-YiOng, X.- R. Lu and L. A. Horrocks
Role of CD14 in Host Response to Infection
Journal:
Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents
Volume:
1
Page:
205-210
Author(s):
A. Verbon
Inhibitor at the Gates, Inhibitor in the Chamber: Allosteric and Competitive Inhibitors of the Proteasome as Prospective Drugs
Journal:
Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents
Volume:
2
Page:
279-301
Author(s):
M. Gaczynska and P.A. Osmulski
The Immune Response to the Parasitic Nematode Trichinella and the Ways to Escape it. From Experimental Studies to Implications for Human Infection.
Journal:
Current Drug Targets - Immune, Endocrine & Metabolic Disorders
Volume:
2
Page:
269-280
Author(s):
Fabrizio Bruschi
Localised Delivery of Therapeutic Agents to CNS Malignancies: Old and New Approaches
Journal:
Current Pharmaceutical Biotechnology
Volume:
3
Page:
257-273
Author(s):
Tracy-Ann Read, Frits Thorsen and Rolf Bjerkvig
The Role of the Cytoskeleton in the Life Cycle of Viruses and Intracellular Bacteria: Tracks, Motors, and Polymerization Machines
Journal:
Current Drug Targets - Infectious Disorders
Volume:
2
Page:
247-264
Author(s):
E. L. Bearer and P. Satpute-Krishnan
Blood-Brain Barrier Penetration and Drug Development from an Industrial Point of View
Journal:
Current Medicinal Chemistry - Central Nervous System Agents
Volume:
2
Page:
187-201
Author(s):
Katharina Mertsch and Jochen Maas
In Vitro Models of the Blood-Brain Barrier: When to Use Which?
Journal:
Current Medicinal Chemistry - Central Nervous System Agents
Volume:
2
Page:
203-209
Author(s):
A(Bert). G. de Boer and P. J. Gaillard
Hepatitis C Virus Proteins as Targets for Drug Development: The Role of Bioinformatics and Modelling
Journal:
Current Drug Targets
Volume:
3
Page:
281-296
Author(s):
A. Lahm, A. Yagnik, A. Tramontano and U. Koch